{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:14:45Z","timestamp":1789510485200,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":3075,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1124\/jpet.116.232702","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T03:15:41Z","timestamp":1464059741000},"page":"164-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Peripheral Administration of a Long-Acting Peptide Oxytocin Receptor Agonist Inhibits Fear-Induced Freezing"],"prefix":"10.1016","volume":"358","author":[{"given":"Meera E.","family":"Modi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Majchrzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari R.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Doran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Osgood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Vanase-Frawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Feyfant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Darvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek L.","family":"Buhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha M.","family":"Kablaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.116.232702_bib1","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0910249107","article-title":"Promoting social behavior with oxytocin in high-functioning autism spectrum disorders","volume":"107","author":"Andari","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.116.232702_bib2","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1038\/npp.2011.138","article-title":"Oxytocin reduces background anxiety in a fear-potentiated startle paradigm: peripheral vs central administration","volume":"36","author":"Ayers","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.116.232702_bib3","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1038\/tp.2013.34","article-title":"Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy","volume":"3","author":"Bakermans-Kranenburg","year":"2013","journal-title":"Transl Psychiatry"},{"key":"10.1124\/jpet.116.232702_bib4","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/mp.2014.132","article-title":"Cerebrospinal fluid and plasma oxytocin concentrations are positively correlated and negatively predict anxiety in children","volume":"20","author":"Carson","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.1124\/jpet.116.232702_bib5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/mabi.200600129","article-title":"Biodegradable injectable in situ depot-forming drug delivery systems","volume":"6","author":"Chitkara","year":"2006","journal-title":"Macromol Biosci"},{"key":"10.1124\/jpet.116.232702_bib6","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.neuroimage.2009.03.083","article-title":"Measurement of cerebral blood volume in mouse brain regions using micro-computed tomography","volume":"47","author":"Chugh","year":"2009","journal-title":"Neuroimage"},{"key":"10.1124\/jpet.116.232702_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0022-5347(25)00348-9","article-title":"Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats","volume":"241","author":"de Wied","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.232702_bib8","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1124\/dmd.111.038778","article-title":"Species independence in brain tissue binding using brain homogenates","volume":"39","author":"Di","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.116.232702_bib9","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/jps.23013","article-title":"Impact of recovery on fraction unbound using equilibrium dialysis","volume":"101","author":"Di","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.116.232702_bib10","first-page":"29","article-title":"On the blood-brain barrier to peptides: accumulation of labelled vasopressin, DesGlyNH2-vasopressin and oxytocin by brain regions","volume":"19","author":"Ermisch","year":"1985","journal-title":"Endocrinol Exp"},{"key":"10.1124\/jpet.116.232702_bib11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1113\/jphysiol.1969.sp008937","article-title":"The clearance and antidiuretic potency of neurohypophysial hormones in man, and their plasma binding and stability","volume":"204","author":"Fabian","year":"1969","journal-title":"J Physiol"},{"key":"10.1124\/jpet.116.232702_bib12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1517\/13543780903066764","article-title":"Investigational vasopressin receptor modulators in the pipeline","volume":"18","author":"Favory","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1124\/jpet.116.232702_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0079-6123(08)00417-2","article-title":"Oxytocin receptors: ligand binding, signalling and cholesterol dependence","volume":"170","author":"Gimpl","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1124\/jpet.116.232702_bib14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.biopsych.2006.05.030","article-title":"Oxytocin increases retention of social cognition in autism","volume":"61","author":"Hollander","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.116.232702_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.npp.1300021","article-title":"Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger\u2019s disorders","volume":"28","author":"Hollander","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.116.232702_bib16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1196\/annals.1410.043","article-title":"Corticotropin-releasing hormone receptor subtypes in the rat anterior pituitary after two types of restraint stress","volume":"1148","author":"Klenerova","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.116.232702_bib17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.neuron.2011.11.030","article-title":"Evoked axonal oxytocin release in the central amygdala attenuates fear response","volume":"73","author":"Knobloch","year":"2012","journal-title":"Neuron"},{"key":"10.1124\/jpet.116.232702_bib18","first-page":"191","article-title":"Simultaneous measurement of arginine vasopressin and oxytocin in plasma and neurohypophyses by radioimmunoassay","volume":"78","author":"Landgraf","year":"1981","journal-title":"Endokrinologie"},{"key":"10.1124\/jpet.116.232702_bib19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1023\/A:1025048802629","article-title":"The emotional brain, fear, and the amygdala","volume":"23","author":"LeDoux","year":"2003","journal-title":"Cell Mol Neurobiol"},{"key":"10.1124\/jpet.116.232702_bib20","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1111\/j.1365-2982.2011.01851.x","article-title":"Oxytocin-immunoreactive innervation of identified neurons in the rat dorsal vagal complex","volume":"24","author":"Llewellyn-Smith","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1124\/jpet.116.232702_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbr.2015.03.035","article-title":"Neural correlates of individual differences in fear learning","volume":"287","author":"MacNamara","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.116.232702_bib22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1054-3589(04)50014-5","article-title":"Brain-fluid barriers: relevance for theoretical controversies regarding vasopressin and oxytocin memory research","volume":"50","author":"McEwen","year":"2004","journal-title":"Adv Pharmacol"},{"key":"10.1124\/jpet.116.232702_bib23","first-page":"65","article-title":"The influence of binding to albumin and alpha 1-acid glycoprotein on the clearance of drugs by the liver","volume":"9","author":"Meijer","year":"1987","journal-title":"Pharm Weekbl Sci"},{"key":"10.1124\/jpet.116.232702_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/brainsci5010003","article-title":"Lipo-oxytocin-1, a novel oxytocin analog conjugated with two palmitoyl groups, has long-lasting effects on anxiety-related behavior and social avoidance in CD157 knockout mice","volume":"5","author":"Mizuno","year":"2015","journal-title":"Brain Sci"},{"key":"10.1124\/jpet.116.232702_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.psyneuen.2014.02.011","article-title":"Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques","volume":"45","author":"Modi","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1124\/jpet.116.232702_bib26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2826.1996.04557.x","article-title":"Oxytocin released within the supraoptic nucleus of the rat brain by positive feedback action is involved in parturition-related events","volume":"8","author":"Neumann","year":"1996","journal-title":"J Neuroendocrinol"},{"key":"10.1124\/jpet.116.232702_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tins.2012.08.004","article-title":"Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors","volume":"35","author":"Neumann","year":"2012","journal-title":"Trends Neurosci"},{"key":"10.1124\/jpet.116.232702_bib28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neubiorev.2014.12.011","article-title":"Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model","volume":"49","author":"Quintana","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.116.232702_bib29","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.biopsych.2009.01.009","article-title":"Systemic propranolol acts centrally to reduce conditioned fear in rats without impairing extinction","volume":"65","author":"Rodriguez-Romaguera","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.116.232702_bib30","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1749-6632.1993.tb55625.x","article-title":"A physiological role of vasopressin in the expression of conditioned fear","volume":"689","author":"Stoehr","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.116.232702_bib31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.yfrne.2011.07.001","article-title":"Prosocial effects of oxytocin and clinical evidence for its therapeutic potential","volume":"32","author":"Striepens","year":"2011","journal-title":"Front Neuroendocrinol"},{"key":"10.1124\/jpet.116.232702_bib32","unstructured":"Thuresson K, Tiberg F, Johansson M, Harwigsson I, Joabsson F, Johnsson M; Camurus AB, assignee (2005) Liquid Depot Formulations WO\/2005\/117830."},{"key":"10.1124\/jpet.116.232702_bib33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1472-8206.1988.tb00634.x","article-title":"Blood binding and tissue uptake of drugs. Recent advances and perspectives","volume":"2","author":"Tillement","year":"1988","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1124\/jpet.116.232702_bib34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00213-012-2702-4","article-title":"Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepoint-dependent manner","volume":"223","author":"Toth","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.232702_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0091-3057(94)90462-6","article-title":"High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats","volume":"49","author":"Uvn\u00e4s-Moberg","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.116.232702_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.1201043","article-title":"Oxytocin selectively gates fear responses through distinct outputs from the central amygdala","volume":"333","author":"Viviani","year":"2011","journal-title":"Science"},{"key":"10.1124\/jpet.116.232702_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0079-6123(08)00418-4","article-title":"Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response","volume":"170","author":"Viviani","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1124\/jpet.116.232702_bib38","doi-asserted-by":"crossref","unstructured":"Wehner JM and Radcliffe RA (2004) Cued and contextual fear conditioning in mice. Curr Protoc Neurosci (Chapter 8, Unit 8 5C).","DOI":"10.1002\/0471142301.ns0805cs27"},{"key":"10.1124\/jpet.116.232702_bib39","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.3390\/ijms15033580","article-title":"Interactive association of drugs binding to human serum albumin","volume":"15","author":"Yang","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.116.232702_bib40","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/endo.133.3.8396014","article-title":"Localization of oxytocin receptor messenger ribonucleic acid in the rat brain","volume":"133","author":"Yoshimura","year":"1993","journal-title":"Endocrinology"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524193573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524193573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.116.232702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T17:18:27Z","timestamp":1740763107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524193573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0022356524193573"],"URL":"https:\/\/doi.org\/10.1124\/jpet.116.232702","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral Administration of a Long-Acting Peptide Oxytocin Receptor Agonist Inhibits Fear-Induced Freezing","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.116.232702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s)","name":"copyright","label":"Copyright"}]}}